These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9041264)

  • 1. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years.
    Wallace JL
    Gastroenterology; 1997 Mar; 112(3):1000-16. PubMed ID: 9041264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAID gastroenteropathy: past, present and future.
    Wallace JL
    Can J Gastroenterol; 1996; 10(7):451-9. PubMed ID: 9113889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors.
    Perini R; Fiorucci S; Wallace JL
    Can J Gastroenterol; 2004 Apr; 18(4):229-36. PubMed ID: 15054499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs: gastroduodenal injury and beyond.
    Bernsdorff KR; Agrawal RM; Brodmerkel GJ
    Dig Dis; 1995; 13(4):251-66. PubMed ID: 8521610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum.
    Thiéfin G; Beaugerie L
    Joint Bone Spine; 2005 Jul; 72(4):286-94. PubMed ID: 16038840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is NSAIDs-related gastrointestinal damage preventable?
    Gargallo CJ; Lanas A
    J Dig Dis; 2013 Feb; 14(2):55-61. PubMed ID: 23216831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal protection by NO from NSAIDs induced injury.
    Rishi RK; Kishore K; Seth SD
    Indian J Physiol Pharmacol; 1996 Oct; 40(4):377-9. PubMed ID: 9055111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs)?
    Brune K
    Drugs; 1990; 40 Suppl 5():12-5. PubMed ID: 2127913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs].
    Zhang YH; Ji H; Peng SX
    Yao Xue Xue Bao; 2007 Apr; 42(4):352-7. PubMed ID: 17633199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs.
    Fiorucci S; Santucci L
    Inflamm Allergy Drug Targets; 2011 Apr; 10(2):133-40. PubMed ID: 21275896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract.
    James MW; Hawkey CJ
    Br J Clin Pharmacol; 2003 Aug; 56(2):146-55. PubMed ID: 12895187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
    Takeuchi K; Yokota A; Tanaka A; Takahira Y
    Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors.
    Buttgereit F; Burmester GR; Simon LS
    Am J Med; 2001 Feb; 110 Suppl 3A():13S-9S. PubMed ID: 11173045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G; Venturi N; Spaggiari S
    Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAIDs, gastrointestinal injury, and cytoprotection.
    Scheiman JM
    Gastroenterol Clin North Am; 1996 Jun; 25(2):279-98. PubMed ID: 9229573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.
    Hooper L; Brown TJ; Elliott R; Payne K; Roberts C; Symmons D
    BMJ; 2004 Oct; 329(7472):948. PubMed ID: 15475342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.